Evidence map›Paper›PMID 12381791›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Impaired recycling of synaptic vesicles after acute perturbation of the presynaptic actin cytoskeleton.

Oleg Shupliakov, Ona Bloom, Jenny S Gustafsson, Ole Kjaerulff, Peter Low, Nikolay Tomilin, Vincent A Pieribone, Paul Greengard, Lennart Brodin

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 240 citations in OpenAlex.

  1. Neuronal Calcium Signaling and Cytoskeletal Dynamics in Neurodegeneration.International journal of molecular sciences · 2026
    Review
  2. Deciphering the Nanoscale Architecture of Presynaptic Actin Using a Micropatterned Presynapse-on-Glass Model.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. The how and why for multiple forms of hippocampal LTP.Frontiers in synaptic neuroscience · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Neuroendocrine Control of Synaptic Transmission by PHAC-1 inThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Presynapses contain distinct actin nanostructures.The Journal of cell biology · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Multiple Roles of Actin in Exo- and Endocytosis.Frontiers in synaptic neuroscience · 2022
    Review
  17. Article
  18. Synaptic tau: A pathological or physiological phenomenon?Acta neuropathologica communications · 2021
    Review
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Oleg ShupliakovNobel Institute for Neurophysiology, Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.
Ona Bloom
Jenny S Gustafsson
Ole Kjaerulff
Peter Low
Nikolay Tomilin
Vincent A Pieribone
Paul Greengard
Lennart Brodin
Rockefeller University · USKarolinska Institutet · SE

Funding

SYNAPSINS: REGULATORS OF NEUROTRANSMITTER RELEASER01MH039327 · NIMH · ROCKEFELLER UNIVERSITY · PI GREENGARD, PAUL · 1985 to 2006
$2.9M
SYNAPSINS: REGULATORS OF NEUROTRANSMITTER RELEASER37MH039327 · NIMH · ROCKEFELLER UNIVERSITY · PI GREENGARD, PAUL · 1991 to 2000
$671k
MOLECULAR BIOLOGY OF PRO- AND EUKARYOTIC CELLST32GM007982 · NIGMS · ROCKEFELLER UNIVERSITY · PI BLOBEL, GUNTER K · 1985 to 2001
$632k
PHYSIOLOGICAL ROLE OF ACTIN IN SYNAPTIC TRANSMISSIONR01NS037823 · NINDS · JOHN B. PIERCE LABORATORY, INC. · PI PIERIBONE, VINCENT A · 2000 to 2002
$508k
NIGMS NIH HHS GM 07982NIGMS NIH HHS T32 GM007982NIMH NIH HHS MH 39327NIMH NIH HHS R01 MH039327NIMH NIH HHS R37 MH039327NINDS NIH HHS R01 NS037823
6 · The paper itself

Abstract

Actin is an abundant component of nerve terminals that has been implicated at multiple steps of the synaptic vesicle cycle, including reversible anchoring, exocytosis, and recycling of synaptic vesicles. In the present study we used the lamprey reticulospinal synapse to examine the role of actin at the site of synaptic vesicle recycling, the endocytic zone. Compounds interfering with actin function, including phalloidin, the catalytic subunit of Clostridium botulinum C2 toxin, and N-ethylmaleimide-treated myosin S1 fragments were microinjected into the axon. In unstimulated, phalloidin-injected axons actin filaments formed a thin cytomatrix adjacent to the plasma membrane around the synaptic vesicle cluster. The filaments proliferated after stimulation and extended toward the vesicle cluster. Synaptic vesicles were tethered along the filaments. Injection of N-ethylmaleimide-treated myosin S1 fragments caused accumulation of aggregates of synaptic vesicles between the endocytic zone and the vesicle cluster, suggesting that vesicle transport was inhibited. Phalloidin, as well as C2 toxin, also caused changes in the structure of clathrin-coated pits in stimulated synapses. Our data provide evidence for a critical role of actin in recycling of synaptic vesicles, which seems to involve functions both in endocytosis and in the transport of recycled vesicles to the synaptic vesicle cluster.

Indexed as

Actin CytoskeletonActinsAnimalsBotulinum ToxinsCytoskeletonEndocytosisLampreysMyosin SubfragmentsPresynaptic TerminalsSynaptic VesiclesActinsBotulinum Toxinsbotulinum toxin type CMyosin Subfragments

Identifiers

PMID12381791
PMCPMC137908
OpenAlexW2165427035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.